American Strategic Investment (NYC) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for American Strategic Investment in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NYC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NYC, but not buy additional shares or sell existing shares.
View NYC analyst ratings or view top-rated stocks.

1 brokerages have issued 12 month target prices for American Strategic Investment's shares. Their NYC share price forecasts range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next year. This suggests that the stock has a possible downside of 12.1%.
View analysts price targets for NYC or view top-rated stocks among Wall Street analysts.

American Strategic Investment's stock was trading at $14.16 on January 1st, 2023. Since then, NYC stock has decreased by 35.7% and is now trading at $9.10.
View the best growth stocks for 2023 here.

American Strategic Investment saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 8,300 shares, a decrease of 14.4% from the August 31st total of 9,700 shares. Based on an average daily volume of 5,100 shares, the short-interest ratio is presently 1.6 days. Currently, 0.6% of the shares of the stock are sold short.
View American Strategic Investment's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our NYC earnings forecast.

American Strategic Investment Co. (NYSE:NYC) released its quarterly earnings data on Friday, August, 11th. The company reported ($4.77) earnings per share for the quarter, missing the consensus estimate of ($1.64) by $3.13. The firm earned $15.78 million during the quarter, compared to the consensus estimate of $16.13 million. American Strategic Investment had a negative net margin of 69.10% and a negative trailing twelve-month return on equity of 13.77%.

Shares of American Strategic Investment reverse split on the morning of Thursday, January 12th 2023. The 1-8 reverse split was announced on Thursday, January 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other American Strategic Investment investors own include G1 Therapeutics (GTHX), Gilead Sciences (GILD), Fluidigm (FLDM), Dynavax Technologies (DVAX), Cumberland Pharmaceuticals (CPIX), Co-Diagnostics (CODX), Aileron Therapeutics (ALRN), Allena Pharmaceuticals (ALNA) and

American Strategic Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "NYC."

Shares of NYC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NYC stock can currently be purchased for approximately $9.10.

American Strategic Investment (NYSE:NYC) has a market capitalization of $21.20 million and generates $64 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or ($22.42) on an earnings per share basis.

American Strategic Investment's mailing address is 650 FIFTH AVENUE 30TH FLOOR, NEW YORK NY, 10019. The official website for the company is www.newyorkcityreit.com. The company can be reached via phone at 212-415-6500 or via email at info@ar-global.com.